AnaptysBio Inc. (AN6)
Market Closed
17 Jul, 20:00
XFRA 
€
50. 58
+2.9
+6.0822%
€
1.82B Market Cap
- P/E Ratio
- Div Yield
40 Volume
-6.06 Eps
€ 47.68
Previous Close Want to track AN6 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AnaptysBio Inc. (AN6) Statistics
Valuation metrics
Market Cap 1.82B
Enterprise value 1.12B
Trailing P/E (ttm) -95.3
Forward P/E -13.17
PEG ratio -2.18
Price/Sales (ttm) 5.49
Price/Book (mrq) 116.06
Enterprise Value/Revenue 5.55
Enterprise Value/EBITDA 31.18
Overview
Shares outstanding 29.03M
Float 19.55M
Shares short -
% Held by insiders 0.06%
% Held by institutions 1.04%
Average volume (10 days) 21
Average volume (90 days) 25
Price summary
52-Week low 16
52-Week high 61.48
Beta 0.41
50-Day moving average 50.39
200-Day moving average 39.4
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.12%
Operating margin -1.36%
Operational effectiveness
Return on assets 0.07%
Return on equity -1.15%
Income Statement
Revenue (ttm) 201.69M
Revenue per share (ttm) 8.22
Quarterly revenue growth (yoy) -0.08%
Gross profit (ttm) 89.92M
EBITDA 69.25M
Net income to common (ttm) -23.25M
Diluted EPS (ttm) -0.88
Quarterly earnings growth (yoy) -0.08%
Balance Sheet
Total cash (mrq) 248.62M
Total cash per share (mrq) 9.84
Total debt (mrq) 240.72M
Total Debt/Equity (mrq) 2,175.84
Current ratio (mrq) 7.58%
Book value per share (mrq) 0.38
Cash Flow
Cash flow statement 3.89M
Levered free cash flow (LFCF) 7.22M
